




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
HowtoWritetheIntroductionS1020489王華斌S1010133陳方城S1010104張李巧Thispptconcludes:definitionandpurpose(定義)rulesforagoodIntrodutionandsomeexceptions(好的引言的原則和例外).reasonsfortherules(原則的解釋).tense(時(shí)態(tài)).people(人稱).citationandabbreviations(引用和縮寫(xiě)).definitionandpurposeThefirstsectionofthetextSupplysufficientbackgroundinformation(背景知識(shí))toallowthereadertounderstandandevaluatetheresultsofthepresentstudyPrevioustherationale(原理)
forthepresentstudyandyourpurpose(目的)
inwritingthepaper.RulesforagoodIntrodutionpresentfirst,withallpossibleclarity,thenatureandscopeoftheprobleminvestigated(主題).Brieflyreviewthepertinentliteraturetoorientthereader(背景).Statethemethodoftheinvestigation.ifdeemednecessary,thereasonsforthechoiceofaparticularmethodshouldbestated(方法和原因).Statetheprincipalresultsoftheinvestigation(結(jié)果).Statetheprincipalcnclusionsofsuggestedbytheresults(結(jié)論).Example
Thebloodbrainbarrier(BBB)formedbytightendothelialcelljunctionsofbraincapillarypreventsalargenumberoftherapeuticcompoundsfromcentralnervoussystem(CNS),includingantibiotics,antineoplasticagentsandCNSactivedrugs.
Methotrexate(MTX)isapromisingantitumordrug.Unfortunately,itisverydifficultforMTXtopenetrateBBBsothattheadministrationofintrathecalinjectionisemployedinclinicaltreatmentforbraintumors.However,thisroutesubjectspatientstooperationwoundsandhighrisks.介紹研究領(lǐng)域及其一般進(jìn)展,提供背景資料背景:以前研究中存在的問(wèn)題ExampleSeveralpharmaceuticalmethodshavebeentriedtoovercomeBBB.First,drugswithproperchemicalstructurescanbemodifiedtoenhancebrainuptakeusuallybyintroductionoflipophilicgroups.Besides,anovelchemicaldeliverysystemhasalsodeveloped(Yoshikawaetal.,1999).However,thisstrategyislargelylimitedbythechemicalstructureofcompounds.Atthesametime,alargenumberoflipophiliccompoundsthatcanpassthroughBBBarerapidlypumpedbackintobloodstreambymulti-drugresistanceproteins(MRPs)includingmultipleorganicaniontransporter(MRP2)andP-glycoprotein(Pgp).Theexistenceofsucheffluxpumpsprovestobeanotherlimitationtothismethod.Second,stericallystabilizedimmunoliposomesareusedforbothchemicaldrugsandgenesdeliverytobrain(Huwyleretal.,1996;ShiandPardridge,2000).However,humanderivedantibodyistooexpensiveandtheefficacyofsuchtechnologyisnotremarkable.文獻(xiàn)回顧:一直在研究的相關(guān)的藥理方法兩個(gè)However指出仍然需要研究的地方ExampleTheobjectiveofthepresentstudywastodeterminewhetherthesizeofnanoparticleshadanyinfluenceonbraintargeting.Noexperimentsconcerningthisaspecthavebeenreported.PBCAnanoparticleswithdifferentsizecouldbepreparedbyadjustingthepolymerizationconditionssuchasmediapH,concentrationofemulsifierandmonomerplusstirringrate.MTXwasusedasthemodeldrugsandinvivoexperimentswerecarriedouttoobtainsomepharmacokineticresults.介紹作者研究目的和活動(dòng):PBCA納米質(zhì)粒研究選擇特定方法和選擇的原因:用MTX做對(duì)照藥物Reasonsfortherules
ThefirstruleisthecardinaloneIftheproblemisnotstatedinareasonable,understandableway,readerwillhavenointerestinyoursolution(簡(jiǎn)明扼要的介紹你的主題).Key:whydidyouchoosethatsubject,andwhyisitimportant?ReasonsfortherulesThesecond(literaturereview)andthird(choiceofmetheod)rulesralatetothefirst(背景和方法).Key:MakereaderunderstandwhattheproblemwasandhowyoutriedtoresolveReasonsfortherulesThestatementofprincipalresultsandconclusions——thecapstoneoftheIntroduction(介紹結(jié)果和結(jié)論很重要)AbitofredundancywiththeabstractisoftendesirableThemistaketheauthorsmaymake:Holdingbacktheirmoreimportantfindingsuntillateinthepaper.(引言中不提重要的發(fā)現(xiàn),而放到論文最后)
“Rendingascientificarticleisn’tthesameasreadingadetectivestory.Wewanttoknowformthestart”(Ratnoff,1981).SomeexceptionInsomereseachareasandjournals,scientificpapersfollowonlythefirstthreerulesKey:lookingatpapersinyourtargetjournalasmodelsSomeexceptionSomefields,theIntroductionhasa“funnel”shape(漏斗狀結(jié)構(gòu),先介紹大的背景,再介紹小的研究方向).
優(yōu)點(diǎn):Aintroductionthusstructuredcanprovideahelpfulandhospitablewelcome(給讀者幫助性的和“好客”的態(tài)度).tense
MuchoftheIntroductionshouldbewritteninpresenttense,becauseyouwillberefferringtoyourproblemandtheestablishedknowledge(一般現(xiàn)在時(shí)為主).可以適當(dāng)用過(guò)去時(shí)描述前人已經(jīng)做過(guò)的工作,用現(xiàn)在完成時(shí)描述一直持續(xù)到現(xiàn)在的工作或研究程度。tensetensetense
Gurkovskayaetal.(2009)foundthattheneuroactivesteroiddehydroepiandrosterone(DHEA)candosedependentlydecreasevoluntaryintakeofethanolinmalerats.Inthatstudy,subjectstrainedtoconsumeethanolreceiveddosesoftheneuroactivesteroidspregnanoloneandDHEAtocomparetheireffectsonethanolconsumption.ThatstudyshowedthatDHEAdecreasedethanolintakemoreeffectivelythanpregnanolone.DHEAproducesawidearrayofphysiologicaleffects,acharacteristicthatmakesdeterminingthespecificmechanismbywhichitaltersethanolintakedifficult.Forinstance,DHEAisaprecursorforestradiolandtestosteroneinperipheraltissues(Lardyetal.,2005)andhasintrinsicandrogenicactivity(Moetal.,2006).DHEAisalsoanegativeallostericmodulatoroftheGABAAreceptorcomplex(Majewskaetal.,1990)thatcanincreasethelevelsofotherneuroactivesteroidsthatmodulatethisreceptor,suchasallopregnanolone(Bernardietal.,2005).ThefactthatDHEAcanserveasaprecursorforestradiolandtestosteroneinperipheraltissuesmaybeproblematicforitsuseinaclinicalsetting(Lardyetal.,2005).AdministrationofexogenousDHEAhasbeenfoundtocauseacne,hirsutism,andalteredmensesinwomenbecauseofitscapacityforincreasingtestosteronelevels(vanVollenhovenetal.,1999;PanjariandDavis,2007).Furthermore,alterationsinthelevelsofsexsteroidshavebeenreportedtoaffectethanolconsumption(LakozaandBarkov,1980;Juarezetal.,2002).Thepresentstudycomparedtheeffectsof3b-acetoxyandrost-5-ene-7,17-dione(7-ketoDHEA)onethanolintakewiththeeffectsofDHEAreportedpreviouslyinthesamegroupofrats(Gurkovskayaetal.,2009).7-ketoDHEAisametaboliteofDHEAthatisnotconvertedtosexhormones(Lardyetal.,1998).7-ketoDHEAistheacetylesterof7-oxoDHEA,anaturallyoccurringmetabolite
ofDHEA(seeFig.1).Invivo,widespreadtissueesteraseshydrolyze7-ketoDHEAtofree7-oxoDHEA(Lund-Peroetal.,1994).person適當(dāng)?shù)厥褂谩癐”,“We”或“Our”,“Thispaper”等詞,以明確地指示作者本人的工作;如:——Weconductedthisstudytodeterminewhether…(Thisstudywasconductedtodeterminewhether…);——Thispaperwillpresent(presents)anewapproachthatprocessthedatamoreefficiently.(Insummary,previousmethodsareallextremelyinefficient.Henceanewapproachisdevelopedtoprocessthedatamoreefficiently.)Citationandabbreviati
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 淮北師范大學(xué)《人居環(huán)境學(xué)》2023-2024學(xué)年第二學(xué)期期末試卷
- 江蘇工程職業(yè)技術(shù)學(xué)院《工程制圖(上)》2023-2024學(xué)年第二學(xué)期期末試卷
- 蘭州石化職業(yè)技術(shù)大學(xué)《市場(chǎng)營(yíng)銷與策劃》2023-2024學(xué)年第二學(xué)期期末試卷
- 浙江農(nóng)林大學(xué)《三維電腦動(dòng)畫(huà)》2023-2024學(xué)年第二學(xué)期期末試卷
- 鄂州職業(yè)大學(xué)《土壤農(nóng)化分析》2023-2024學(xué)年第二學(xué)期期末試卷
- 巢湖學(xué)院《客戶服務(wù)文化構(gòu)建》2023-2024學(xué)年第二學(xué)期期末試卷
- 內(nèi)浮頂柴油罐清洗施工方案
- 北京中醫(yī)藥大學(xué)《兒童產(chǎn)品展示設(shè)計(jì)》2023-2024學(xué)年第二學(xué)期期末試卷
- 華中師范大學(xué)《中外經(jīng)典文學(xué)作品賞析》2023-2024學(xué)年第二學(xué)期期末試卷
- 長(zhǎng)江職業(yè)學(xué)院《運(yùn)動(dòng)處方理論與實(shí)踐》2023-2024學(xué)年第二學(xué)期期末試卷
- 美團(tuán)外賣騎手服務(wù)合同(2025年度)
- 應(yīng)急預(yù)案解讀與實(shí)施
- 2025年《國(guó)有企業(yè)領(lǐng)導(dǎo)人員腐敗案例剖析》心得體會(huì)樣本(3篇)
- 廣告行業(yè)安全培訓(xùn)詳細(xì)介紹
- 2024-2029年全球及中國(guó)氨能源(綠氨)應(yīng)用可行性研究與投資戰(zhàn)略規(guī)劃分析報(bào)告
- 2025福南平市建武夷水務(wù)發(fā)展限公司招聘21人高頻重點(diǎn)提升(共500題)附帶答案詳解
- 2025年上半年工業(yè)和信息化部裝備工業(yè)發(fā)展中心應(yīng)屆畢業(yè)生招聘(第二批)易考易錯(cuò)模擬試題(共500題)試卷后附參考答案
- 2025年中遠(yuǎn)海運(yùn)物流有限公司招聘筆試參考題庫(kù)含答案解析
- 2024年廣州市海珠區(qū)衛(wèi)生健康系統(tǒng)招聘事業(yè)單位工作人員筆試真題
- 一科一品一骨科護(hù)理
- 加氣站安全培訓(xùn)課件
評(píng)論
0/150
提交評(píng)論